Publications by the researcher in collaboration with María Luisa Laorden Carrasco (16)

2021

  1. Cardiac changes in parkinson’s disease: Lessons from clinical and experimental evidence

    International Journal of Molecular Sciences, Vol. 22, Núm. 24

  2. Cardiac tyrosine hydroxylase activation and MB-COMT in dyskinetic monkeys

    Scientific Reports, Vol. 11, Núm. 1

  3. Could small heat shock protein hsp27 be a first‐line target for preventing protein aggregation in parkinson’s disease?

    International Journal of Molecular Sciences, Vol. 22, Núm. 6, pp. 1-13

2020

  1. Cardiac Noradrenaline Turnover and Heat Shock Protein 27 Phosphorylation in Dyskinetic Monkeys

    Movement Disorders, Vol. 35, Núm. 4, pp. 698-703

2012

  1. Effects of surgery and/or remifentanil administration on the expression of pERK1/2, c-Fos and dynorphin in the dorsal root ganglia in mice

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 385, Núm. 4, pp. 397-409

2010

  1. Enhanced tyrosine hydroxylase phosphorylation in the nucleus accumbens and nucleus tractus solitarius-A2 cell group after morphine-conditioned place preference

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 382, Núm. 5-6, pp. 525-534

  2. Increased spinal dynorphin levels and phospho-extracellular signal-regulated kinases 1 and 2 and c-Fos immunoreactivity after surgery under remifentanil anesthesia in mice

    Molecular Pharmacology, Vol. 77, Núm. 2, pp. 185-194

2009

  1. Effects of rolipram and diazepam on the adaptive changes induced by morphine withdrawal in the hypothalamic paraventricular nucleus

    European Journal of Pharmacology, Vol. 620, Núm. 1-3, pp. 1-8

2007

  1. Differential involvement of 3′, 5′-cyclic adenosine monophosphate-dependent protein kinase in regulation of Fos and tyrosine hydroxylase expression in the heart after naloxone induced morphine withdrawal

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 374, Núm. 4, pp. 293-303

  2. Phosphodiesterase 4 inhibitors, rolipram and diazepam block the adaptive changes observed during morphine withdrawal in the heart

    European Journal of Pharmacology, Vol. 570, Núm. 1-3, pp. 1-9

2004

  1. Changes in c-fos expression in the rat during morphine withdrawal. Involvement of α2-adrenoceptors

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 370, Núm. 1, pp. 17-25

  2. Increase of tyrosine hydroxylase levels and activity during morphine withdrawal in the heart

    European Journal of Pharmacology, Vol. 506, Núm. 2, pp. 119-128

  3. Morphine withdrawal-induced c-fos expression in the heart: A peripheral mechanism

    European Journal of Pharmacology, Vol. 487, Núm. 1-3, pp. 117-124

2003

  1. Activation of c-fos expression in the heart after morphine but not U-50,488H withdrawal

    British Journal of Pharmacology, Vol. 138, Núm. 4, pp. 626-633

2001

  1. Evidence for a peripheral mechanism in cardiac opioid withdrawal

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 364, Núm. 3, pp. 193-198

2000

  1. Changes in catecholaminergic pathways innervating paraventricular nucleus and pituitary-adrenal axis response during morphine dependence: Implication of α1- and α2-adrenoceptors

    Journal of Pharmacology and Experimental Therapeutics, Vol. 293, Núm. 2, pp. 578-584